25 employees
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
2020
$47M
from 4 investors over 4 rounds
Egle Therapeutics raised $47M on October 22, 2021
Investors: FundPlus, Bioqube Ventures, Takeda UK Limited and EQT Life Sciences